We further found that the expression levels of PDIA6 and PDIA4 were higher in breast cancer tissues compared to normal breast tissues, with the highest level observed in the TNBC subtype, suggesting that PDIA6 and PDIA4 could serve as prognostic markers and therapeutic targets for TNBC. This evidence concerns the gene PDIA6 and breast carcinoma.